Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma

Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma

British Journal of Cancer 115, 290 (26 July 2016). doi:10.1038/bjc.2016.209

Authors: Michele Reni, Gianpaolo Balzano, Silvia Zanon, Paolo Passoni, Roberto Nicoletti, Paolo Giorgio Arcidiacono, Gino Pepe, Claudio Doglioni, Clara Fugazza, Domenica Ceraulo, Massimo Falconi & Luca Gianni

from Cancer via ola Kala on Inoreader http://ift.tt/29Y7npy
via IFTTT